South Florida Research Phase I-IV — Miami, Florida

South Florida Research Phase I-IV is a clinical research site located in Miami, Florida, United States 33166.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

South Florida Research Phase I-IV has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Alzheimer Disease, Mania, Bipolar Disorder.

Sponsors: Eli Lilly and Company, Bristol-Myers Squibb, Bellerophon Pulse Technologies.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Florida Research Phase I-IV?

South Florida Research Phase I-IV has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Florida Research Phase I-IV conducted?

South Florida Research Phase I-IV has 3 clinical trials on record, with 2 currently active. Their work covers Alzheimer Disease, Mania, Bipolar Disorder.

Is South Florida Research Phase I-IV accredited by Crixeo Health?

South Florida Research Phase I-IV has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Florida Research Phase I-IV?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.